Notification That Annual Report Will Be Submitted Late (nt 10-k)
01 Oktober 2018 - 10:54PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
One):
[X] Form 10-K [ ] Form 20-F [ ] Form
11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form
N-SAR [ ] Form N-CSR
|
|
For
Period Ended:
|
June
30, 2018
|
|
[ ] Transition
Report on Form 10-K
[ ] Transition
Report on Form 20-F
[ ] Transition
Report on Form 11-K
[ ] Transition
Report on Form 10-Q
[ ] Transition
Report on Form N-SAR
|
|
For
the Transition Period Ended:
|
|
|
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
CURATIVE
BIOSCIENCES, INC.
Full
Name of Registrant
Former
Name if Applicable
2
South Biscayne Blvd. Suite 3760
Address
of Principal Executive Office (Street and Number)
Miami,
FL 33131
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate.)
|
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
|
|
|
[X]
|
(b)
|
The
subject annual report, semiannual report, transition report on Form 10Q, Form 20F, 11K or Form NSAR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report of transition report on Form 10QSB, or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
The
compilation, dissemination and review of the information required to be presented in the Form 10-K for the period ending June
30, 2018 could not be completed without undue hardship and expense to the registrant. The registrant anticipates that it will
file its Form 10-K for the year ended June 30, 2018 within the “grace” period provided by Securities Exchange Act
Rule 12b-25.
(Attach
extra Sheets if Needed)
PART
IV — OTHER INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
|
Richard
Damion, CEO
|
|
(949)
|
|
287-3164
|
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed ? If the answer is no, identify report(s).
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
CURATIVE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
|
Date:
|
October
1, 2018
|
|
By:
|
/s/
Richard Damion
|
|
|
|
|
|
Richard
Damion
|
|
|
|
|
|
Chief Executive Officer
|
Curative Biosciences (CE) (USOTC:CBDX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Curative Biosciences (CE) (USOTC:CBDX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
